187 related articles for article (PubMed ID: 2547331)
21. Tumour markers in gastric cancer.
Roberts PJ; Haglund C; Onali M; Kuusela P
Ann Chir Gynaecol; 1989; 78(1):38-40. PubMed ID: 2667447
[TBL] [Abstract][Full Text] [Related]
22. Clinical value of squamous cell carcinoma antigen (SCC-A) in Egyptian gynecologic cancer patients.
Salman T; el-Ahmady O; Tony O; Darwish M
Anticancer Res; 1997; 17(4B):3083-6. PubMed ID: 9329607
[TBL] [Abstract][Full Text] [Related]
23. Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer.
Ando S; Kimura H; Iwai N; Shima M; Ando M; Kuriyama T
Anticancer Res; 2001; 21(4B):3085-92. PubMed ID: 11712815
[TBL] [Abstract][Full Text] [Related]
24. [Clinical evaluation of serum CA-50 and CA 19-9 in gynecological tumors].
Suzuki M; Ohwada M; Tamada T; Sakurabayashi I; Kawai T
Rinsho Byori; 1989 Jul; 37(7):784-8. PubMed ID: 2558243
[TBL] [Abstract][Full Text] [Related]
25. Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer.
Tas F; Aydiner A; Topuz E; Yasasever V; Karadeniz A; Saip P
J Exp Clin Cancer Res; 2000 Dec; 19(4):477-81. PubMed ID: 11277326
[TBL] [Abstract][Full Text] [Related]
26. [Tumor markers in gynecology. General review].
Briese V; Strache RR
Zentralbl Gynakol; 1988; 110(5):257-66. PubMed ID: 3287800
[TBL] [Abstract][Full Text] [Related]
27. Tumor marker concentrations in normal and malignant tissues of colorectal cancer patients and their prognostic relevance.
Gebauer G; Müller-Ruchholtz W
Anticancer Res; 1997; 17(4A):2731-4. PubMed ID: 9252706
[TBL] [Abstract][Full Text] [Related]
28. [Tumor markers in colorectal cancer].
Gorgone S; Alleruzzo A; Rizzo AG; Labruto G; Di Pietro N; Sampiero G; Barbuscia M; Arsena A
Minerva Chir; 1992 Aug; 47(15-16):1249-52. PubMed ID: 1407623
[TBL] [Abstract][Full Text] [Related]
29. Trophoblastic markers and CEA in non-small cell lung cancer: the comparison studies of tumour cells expression and serum concentration.
Słodkowska J; Szturmowicz M; Giedronowicz D; Rudzinski P; Sakowicz A; Kupis W
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():190-8. PubMed ID: 9337537
[TBL] [Abstract][Full Text] [Related]
30. [Levels of circulating tumor-associated glycoprotein (TAG-72) in patients with carcinoma using a novel tumor marker, CA 72-4].
Ohuchi N; Matoba N; Taira Y; Takahashi K; Sakai N; Sato K; Fujita N; Mochizuki F; Nishihira T; Mori S
Gan To Kagaku Ryoho; 1988 Sep; 15(9):2767-72. PubMed ID: 3166366
[TBL] [Abstract][Full Text] [Related]
31. [The place of tumor markers in breast and gynecologic neoplasms].
Gosselin P; Cazin JL; Demaille MC; Sulman C
Rev Fr Gynecol Obstet; 1988; 83(7-9):535-40. PubMed ID: 3057569
[TBL] [Abstract][Full Text] [Related]
32. [Significance of CA 125 antigen levels in patients with ovarian cancer].
Shimizu Y; Fujiwara H; Akagaki E; Hirota K; Kono M; Irie T; Miura S; Okudaira Y
Gan To Kagaku Ryoho; 1986 Jan; 13(1):46-52. PubMed ID: 3455806
[TBL] [Abstract][Full Text] [Related]
33. [The value of tumor markers in colorectal cancer].
Peters KM; Grundmann R
Leber Magen Darm; 1989 Jan; 19(1):18-25. PubMed ID: 2927234
[TBL] [Abstract][Full Text] [Related]
34. Expression of CEA and trophoblastic cell markers by lung carcinoma in association with histological characteristics and serum marker levels.
Slodkowska J; Szturmowicz M; Rudzinski P; Giedronowicz D; Sakowicz A; Androsiuk W; Zakrzewska-Rowinska E
Eur J Cancer Prev; 1998 Feb; 7(1):51-60. PubMed ID: 9511851
[TBL] [Abstract][Full Text] [Related]
35. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors.
Engelen MJ; de Bruijn HW; Hollema H; ten Hoor KA; Willemse PH; Aalders JG; van der Zee AG
Gynecol Oncol; 2000 Jul; 78(1):16-20. PubMed ID: 10873403
[TBL] [Abstract][Full Text] [Related]
36. A multicentre evaluation of tumour marker determinations using the automatic Enzymun-Test Systems ES 300 and ES 600/700.
van Dalen A; Kessler AC
Eur J Clin Chem Clin Biochem; 1996 Apr; 34(4):377-84. PubMed ID: 8704058
[TBL] [Abstract][Full Text] [Related]
37. [Tumor markers in human breast cancer].
Takami H; Shikata J
Gan To Kagaku Ryoho; 1987 Nov; 14(11):2998-3003. PubMed ID: 3479050
[TBL] [Abstract][Full Text] [Related]
38. Analysis of the prognostic significance of cytosolic determination of CA 125 tumor-associated antigen, carcinoembryonic antigen and squamous cell carcinoma antigen in patients with nonsmall cell lung carcinoma.
Picardo AL; Diez M; Torres A; Maestro M; Ortega D; Hernando F; Gómez A; Garcia-Asenjo J; Balibrea JL
Cancer; 1996 Mar; 77(6):1066-72. PubMed ID: 8635125
[TBL] [Abstract][Full Text] [Related]
39. Significance of tumour markers in ovarian cancer.
Bhatavdekar JM; Shah NG; Trivedi SN; Karelia NH
Indian J Cancer; 1987 Mar; 24(1):1-8. PubMed ID: 2448222
[No Abstract] [Full Text] [Related]
40. [Critical study of current tumoral markers].
Touitou Y; Bogdan A
Bull Cancer; 1988; 75(3):247-62. PubMed ID: 2453233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
